Citadel Advisors’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
VCM
RIM
ETC
AIC
Citadel Advisors's ASPI Position: Q1 2026 in Review
Citadel Advisors reduced its ASP Isotopes (ASPI) stake by 55% in Q1 2026, selling an estimated $5.66M and leaving 768,006 shares worth $3.39M. The position accounts for ﹤0.01% of the portfolio, ranked #5017.
Citadel Advisors first reported a position in ASPI in Q4 2023 and has held it in 6 quarters since. The position peaked at $11.2M in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.
- Citadel Advisors held 768,006 shares of ASP Isotopes worth $3.39M as of Q1 2026.
- Citadel Advisors sold 957,547 ASP Isotopes shares in Q1 2026, an estimated $5.66M.
- ASP Isotopes made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5017 holding.
- Citadel Advisors first reported a position in ASP Isotopes in Q4 2023 and has held it in 6 quarters since.
- Citadel Advisors's ASP Isotopes position peaked at $11.2M in Q3 2025.
- 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.